These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36149183)

  • 21. Acute biphenotypic leukemia arising in a patient with essential thrombocythemia.
    Wong GC; Lee LH
    Am J Hematol; 2006 Aug; 81(8):624-6. PubMed ID: 16823822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential thrombocythemia and acute leukemia.
    Ferrari D; Ticozzelli G; De Vizzi M; Corigliano P; De Vizzi G
    Haematologica; 1993; 78(6):401-2. PubMed ID: 8175035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical update in polycythemia vera and essential thrombocythemia.
    Tefferi A; Solberg LA; Silverstein MN
    Am J Med; 2000 Aug; 109(2):141-9. PubMed ID: 10967156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis and management of essential thrombocythemia.
    Beer PA; Green AR
    Hematology Am Soc Hematol Educ Program; 2009; ():621-8. PubMed ID: 20008247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia.
    Suleiman Y; Dalia S; Liu JJ; Bowers JW; Padron E; Lancet JE; Fulp W; Moscinski LC; Komrokji RS; Zuckerman KS; Zhang L
    Leuk Res; 2016 Mar; 42():52-8. PubMed ID: 26894965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion.
    Sterkers Y; Preudhomme C; Laï JL; Demory JL; Caulier MT; Wattel E; Bordessoule D; Bauters F; Fenaux P
    Blood; 1998 Jan; 91(2):616-22. PubMed ID: 9427717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of essential thrombocythemia].
    Alvarez-Larrán A; Cervantes F; Besses C
    Med Clin (Barc); 2013 Sep; 141(6):260-4. PubMed ID: 23490491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study.
    Birgegård G; Folkvaljon F; Garmo H; Holmberg L; Besses C; Griesshammer M; Gugliotta L; Wu J; Achenbach H; Kiladjian JJ; Harrison CN
    Leuk Res; 2018 Nov; 74():105-109. PubMed ID: 30368038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?
    Nazha A; Gerds AT
    Oncologist; 2016 Apr; 21(4):475-80. PubMed ID: 26975864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anagrelide compared with hydroxyurea in essential thrombocythemia: a meta-analysis.
    Samuelson B; Chai-Adisaksopha C; Garcia D
    J Thromb Thrombolysis; 2015 Nov; 40(4):474-9. PubMed ID: 25894476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is hydroxyurea leukemogenic in essential thrombocythemia?
    Tefferi A
    Blood; 1998 Aug; 92(4):1459-60; author reply 1460-1. PubMed ID: 9694740
    [No Abstract]   [Full Text] [Related]  

  • 32. Leukemic transformation in essential thrombocythemia.
    Bhatt VR
    Future Oncol; 2014 Dec; 10(16):2593-602. PubMed ID: 25531047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2019 Jan; 94(1):133-143. PubMed ID: 30281843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Subcutaneous myeloid sarcoma in a patient with essential thrombocythemia that transformed into acute myeloid leukemia].
    Kuroda H; Jomen W; Yoshida M; Usami M; Shimoyama S; Yamada M; Abe T; Sakurai T; Fujii S; Maeda M; Fujita M; Nagashima K; Uemura S; Kanari Y; Kato J
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):215-9. PubMed ID: 25743142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors.
    Cerquozzi S; Tefferi A
    Blood Cancer J; 2015 Nov; 5(11):e366. PubMed ID: 26565403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)].
    Hayashi S; Iwama H; Uchida Y; Kawakubo K; Inatomi Y; Nagasu M; Miyazawa K; Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1997 May; 38(5):445-7. PubMed ID: 9194391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rare CALR variant mutation and a review of CALR in essential thrombocythemia.
    Diep R; Metjian A
    J Thromb Thrombolysis; 2018 Apr; 45(3):457-462. PubMed ID: 29411299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms.
    Choi HS; Hong J; Hwang SM; Lee JH; Ma Y; Kim SA; Lee JY; Lee JO; Bang SM
    Ann Hematol; 2021 Oct; 100(10):2567-2574. PubMed ID: 34331110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis.
    Loscocco GG; Antonioli E; Romano I; Vergoni F; Rotunno G; Mannelli F; Guglielmelli P; Vannucchi AM
    Am J Hematol; 2021 Jun; 96(6):749-754. PubMed ID: 33719069
    [No Abstract]   [Full Text] [Related]  

  • 40. Is treatment with hydroxyurea leukemogenic in patients with essential thrombocythemia? An analysis of three new cases of leukaemic transformation and review of the literature.
    Liozon E; Brigaudeau C; Trimoreau F; Desangles F; Fermeaux V; Praloran V; Bordessoule D
    Hematol Cell Ther; 1997 Feb; 39(1):11-8. PubMed ID: 9088933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.